-
公开(公告)号:WO2004018010A3
公开(公告)日:2004-07-08
申请号:PCT/US0324769
申请日:2003-08-07
申请人: CHITOGENICS INC , UNIV LEIDEN , KYDONIEUS AGIS , ELSON CLIVE , THANOU MAYA
发明人: KYDONIEUS AGIS , ELSON CLIVE , THANOU MAYA
CPC分类号: A61K31/727 , A61K45/06 , A61K47/24 , A61K47/36 , A61K48/00
摘要: The present invention provides methods and compositions for delivering a therapeutic agent across a membrane that has limited permeability for the therapeutic agent. The method includes delivering the therapeutic agent to the membrane in a composition which includes a sulphated chitinous polymer as a primary carrier.
摘要翻译: 本发明提供了用于递送治疗剂穿过具有有限的治疗剂渗透性的膜的方法和组合物。 该方法包括将治疗剂以包含硫酸化几丁质聚合物作为主要载体的组合物递送至膜。
-
公开(公告)号:WO2008078102A2
公开(公告)日:2008-07-03
申请号:PCT/GB2007004967
申请日:2007-12-21
申请人: IMUTHES LTD , UNIV WITWATERSRAND , MILLER ANDREW DAVID , ARBUTHNOT PATRICK , JORGENSEN MICHAEL , KELLER MICHAEL , KAMALY NAZILA , AISSAOUI ABDERRAHIM , THANOU MAYA
发明人: MILLER ANDREW DAVID , ARBUTHNOT PATRICK , JORGENSEN MICHAEL , KELLER MICHAEL , KAMALY NAZILA , AISSAOUI ABDERRAHIM , THANOU MAYA
IPC分类号: A61K9/127 , A61K47/34 , A61K47/48 , C07C237/22 , C07F9/10 , C07J41/00 , C08G73/02 , C12N15/11 , C12N15/88
CPC分类号: C07C237/22 , A01K2267/0337 , A61K9/1272 , A61K47/34 , A61K47/543 , A61K47/6907 , A61K47/6911 , A61K48/0025 , C12N15/111 , C12N15/88 , C12N2310/14 , C12N2320/32 , C12N2730/10111 , Y10T428/2984
摘要: The present invention provides a lipid of the formula (I) R 3 R 4 N-[Y] q -(C p H 2p )-X-Linker-NR 1 R 2 (I) wherein R 3 and R 4 are independently selected from H and hydrocarbyl groups; q is an integer selected from 1 to 10; Y represents a group (C n H 2n )NR 5 , wherein (i) when q is 1, n is 2, or (ii) when q is greater than 1, each Y may be the same or different and each n is an integer independently selected from 1 to 10, with the proviso that for at least one unit Y, n is 2, and (iii) each R 5 is independently selected from H and hydrocarbyl groups; p is an integer selected from 1 to 10; X is an optional group selected from -NR 7 -, -C(=O)-N R 8 -, -NR 9 -C(=O)-, -C(=O)-, -O-, and -NR 10 -C(=0)0-, wherein each R 7 , R 8 , R 9 and R 10 is independently selected from H and hydrocarbyl groups, Linker is an optional group selected from amino acid residues, peptide residues and groups of the formula -(OCH 2 CH 2 ) 1-10 , -NR 6 -(CvH 2v )-C(=O)-, wherein R 6 is H or a hydrocarbyl group and v is an integer selected from 1 to 11, and -C(=0)-(CH 2 ) 0-10 -CH 2 -C(=0)-; R 1 is selected from acyclic groups having from 4 to 30 carbon atoms; and R 2 is selected from H and acyclic groups having from 4 to 30 carbon atoms. Said lipids can be used in a delivery vehicle (e.g. micelle or liposome) for the delivery of one or more (therapeutic or diagnostic) agents.
摘要翻译: 本发明提供式(I)的脂类R 3 R 4 N - [Y] q - (C p 其中R 3是氢原子,其中R 3,R 2,R 2,R 2,R 2,R 2, 和R 4独立地选自H和烃基; q是从1至10的整数; Y表示一个基团(C n H n H 2n)NR 5,其中(i)当q为1时,n为2或(ii )当q大于1时,每个Y可以相同或不同,并且每个n是独立地选自1至10的整数,条件是对于至少一个单元Y,n是2,和(iii)每个R 5个独立地选自H和烃基; p是从1到10的整数; X是选自-NR 7 - , - C(= O)-NR 8 - , - NR 9 -C( = O) - , - C(= O) - , - O-和-NR 10 -C(= O)O-,其中每个R 7,R R 9,R 9和R 10独立地选自H和烃基,连接子是选自氨基酸残基,肽残基的任选基团 和式 - (OCH 2 CH 2 CH 2)1 - , - NR 6 - (C v H C(= O) - ,其中R 6为H或烃基,v为选自1至11的整数,且-C(= O ) - (CH 2 SUB>) 0-10 SUB> -CH 2 SUB> -C(= O) - ; R 1选自具有4至30个碳原子的无环基团; R 2选自H和具有4-30个碳原子的无环基。 所述脂质可用于递送载体(例如胶束或脂质体)中以递送一种或多种(治疗或诊断)试剂。
-
公开(公告)号:WO2010082008A1
公开(公告)日:2010-07-22
申请号:PCT/GB2009/000090
申请日:2009-01-14
发明人: THANOU, Maya , WHITBY, Max , QUIRKE, Nick
IPC分类号: C01B31/02
CPC分类号: A61K9/0021 , A61M37/0015 , A61M2037/0023 , A61M2037/003 , A61M2037/0046 , A61M2037/0053 , A61M2037/0061 , B82Y30/00 , B82Y40/00 , C01B32/05 , C01B32/158
摘要: The present invention provides a process of making a nanopipe array comprising spaced bundles of nanopipes and a process of making individual nanopipe bundles. The array or bundle can be used in a device for the delivery of a substance, for example, the delivery of a substance into a patient for the treatment of a disease or condition.
摘要翻译: 本发明提供了一种制备纳米管阵列的方法,其包括间隔开的纳米管束,以及制备单独的纳米管束的方法。 阵列或束可以用于递送物质的装置中,例如将物质输送到患者中以治疗疾病或病症。
-
公开(公告)号:WO2011061541A1
公开(公告)日:2011-05-26
申请号:PCT/GB2010/051925
申请日:2010-11-19
申请人: MEDICAL RESEARCH COUNCIL , IMPERIAL INNOVATIONS LIMITED , KAMALY, Nazila , KALBER, Tammy, Louise , KENNY, Gavin, David , THANOU, Maya , MILLER, Andrew, David , BELL, Jimmy
发明人: KAMALY, Nazila , KALBER, Tammy, Louise , KENNY, Gavin, David , THANOU, Maya , MILLER, Andrew, David , BELL, Jimmy
IPC分类号: A61K49/18
CPC分类号: A61K49/1812 , B82Y5/00 , Y10S977/773
摘要: The present invention provides novel liposomes comprising Gd.DOTA.DSA (gadolinium (III) 2-{4,7-bis-carboxymethyl-10-[( N , N -distearylamidomethyl- N `-amido-methyl]-1,4,7,10- tetra-azacyclododec-1-yl}-acetic acid), characterised in that said liposome further comprises a neutral, fully saturated phospholipid component ( e.g. DSPC (1,2-distearoyl- sn -glycero-3-phospocholine]), which are of particular use in the preparation of magnetic resonance contrast agents for enhancing a magnetic resonance image of tumours in a mammal.
摘要翻译: 本发明提供了包含Gd.DOTA.DSA(钆(III)2- {4,7-双 - 羧甲基-10 - [(N,N-二硬脂酰氨基甲基-N'-酰胺基 - 甲基] 7,10-四氮杂环十二烷-1-基} - 乙酸),其特征在于所述脂质体还包含中性完全饱和的磷脂组分(例如DSPC(1,2-二硬脂酰-sn-甘油-3-磷酸胆碱)) ,其特别用于制备用于增强哺乳动物肿瘤的磁共振图像的磁共振造影剂。
-
公开(公告)号:WO2008078102A3
公开(公告)日:2008-07-03
申请号:PCT/GB2007/004967
申请日:2007-12-21
申请人: IMUTHES LIMITED , UNIVERSITY OF THE WITWATERSRAND , MILLER, Andrew, David , ARBUTHNOT, Patrick , JORGENSEN, Michael , KELLER, Michael , KAMALY, Nazila , AISSAOUI, Abderrahim , THANOU, Maya
发明人: MILLER, Andrew, David , ARBUTHNOT, Patrick , JORGENSEN, Michael , KELLER, Michael , KAMALY, Nazila , AISSAOUI, Abderrahim , THANOU, Maya
IPC分类号: A61K9/127 , A61K47/34 , A61K47/48 , C07C237/22 , C07F9/10 , C07J41/00 , C08G73/02 , C12N15/88
摘要: The present invention provides a lipid of the formula (I) R 3 R 4 N-[Y] q -(C p H 2p )-X-Linker-NR 1 R 2 (I) wherein R 3 and R 4 are independently selected from H and hydrocarbyl groups; q is an integer selected from 1 to 10; Y represents a group (C n H 2n )NR 5 , wherein (i) when q is 1, n is 2, or (ii) when q is greater than 1, each Y may be the same or different and each n is an integer independently selected from 1 to 10, with the proviso that for at least one unit Y, n is 2, and (iii) each R 5 is independently selected from H and hydrocarbyl groups; p is an integer selected from 1 to 10; X is an optional group selected from -NR 7 -, -C(=O)-N R 8 -, -NR 9 -C(=O)-, -C(=O)-, -O-, and -NR 10 -C(=0)0-, wherein each R 7 , R 8 , R 9 and R 10 is independently selected from H and hydrocarbyl groups, Linker is an optional group selected from amino acid residues, peptide residues and groups of the formula -(OCH 2 CH 2 ) 1-10 , -NR 6 -(CvH 2v )-C(=O)-, wherein R 6 is H or a hydrocarbyl group and v is an integer selected from 1 to 11, and -C(=0)-(CH 2 ) 0-10 -CH 2 -C(=0)-; R 1 is selected from acyclic groups having from 4 to 30 carbon atoms; and R 2 is selected from H and acyclic groups having from 4 to 30 carbon atoms. Said lipids can be used in a delivery vehicle (e.g. micelle or liposome) for the delivery of one or more (therapeutic or diagnostic) agents.
-
6.
公开(公告)号:WO2004018010A2
公开(公告)日:2004-03-04
申请号:PCT/US2003/024769
申请日:2003-08-07
发明人: KYDONIEUS, Agis , ELSON, Clive , THANOU, Maya
IPC分类号: A61M
CPC分类号: A61K31/727 , A61K45/06 , A61K47/24 , A61K47/36 , A61K48/00
摘要: The present invention provides methods and compositions for delivering a therapeutic agent across a membrane that has limited permeability for the therapeutic agent. The method includes delivering the therapeutic agent to the membrane in a composition which includes a sulphated chitinous polymer as a primary carrier.
摘要翻译: 本发明提供了用于递送治疗剂的方法和组合物,所述方法和组合物跨越对治疗剂具有有限渗透性的膜。 该方法包括将治疗剂递送到包含硫酸化壳多糖聚合物作为主要载体的组合物中的膜上。
-
-
-
-
-